Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Bei Gene, Ltd. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2024	BUY	$215.53 - $274.5 $2.51 Million - $3.2 Million	11,640 New	11,640 $2.51 Million
Q1 2023 May 15, 2023	BUY	$215.53 - $274.5 $2.51 Million - $3.2 Million	11,640 New	11,640 $2.51 Million
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $56,659 - $91,512	-227 Reduced 10.75%	1,884 $684,000
Q2 2021 Aug 16, 2021	SELL	$292.75 - $367.01 $432,684 - $542,440	-1,478 Reduced 41.18%	2,111 $724,000
Q1 2021 May 17, 2021	SELL	$260.64 - $382.12 $521,280 - $764,240	-2,000 Reduced 35.78%	3,589 $1.25 Million
Q4 2020 Feb 16, 2021	SELL	$221.31 - $316.61 $1.17 Million - $1.68 Million	-5,300 Reduced 48.67%	5,589 $1.44 Million
Q3 2020 Nov 16, 2020	BUY	$189.18 - $286.44 $834,472 - $1.26 Million	4,411 Added 68.09%	10,889 $3.12 Million
Q2 2020 Aug 14, 2020	BUY	$123.9 - $195.41 $251,517 - $396,682	2,030 Added 45.64%	6,478 $1.22 Million
Q1 2020 May 15, 2020	BUY	$121.84 - $173.19 $78,830 - $112,053	647 Added 17.02%	4,448 $548,000
Q4 2019 Feb 14, 2020	BUY	$115.78 - $208.34 $382,189 - $687,730	3,301 Added 660.2%	3,801 $630,000
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $60,305 - $74,145	500 New	500 $61,000
Q2 2018 Aug 14, 2018	SELL	$152.5 - $216.77 $838,750 - $1.19 Million	-5,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$97.41 - $177.22 $535,755 - $974,710	5,500 New	5,500 $924,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.91 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.16 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$935 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$899 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$669 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account